RecruitingNCT04041479
Study of brain-signal-guided rTMS for resistant depression
About this title
Read the official source — NCT04041479Device studyAges 22–65United States
Understand this study
Who could participate?
Listed age limits: 22 years to 65 years.
- Listed locations
- Stanford and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 17, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 348
- Sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 22 Years to 65 Years
- Official registry ID
- NCT04041479
- Official title
Show the full official title
Efficacy of Biomarker-guided rTMS for Treatment Resistant Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Stanford · New York
Questions about this study
Who is behind this study?
The study sponsor is Weill Medical College of Cornell University, a university.
Who can participate?
Listed age limits: 22 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
